Roche Pharmaceutical Development and Sales Overview

Molecular Lab CER-Constant Exchange Rates CHFbn 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 YTD Sep 2020 ■ Virology ■Blood Screening Cervical Cancer qPCR&NAP 2022 vs. 2021 CER growth -8% +12% -28% 0% +19% -20% +5% -7% YTD Sep 2021 YTD Sep 2022 MD Systems ■Microbiology Other Roche 173

View entire presentation